Cell Cryopreservation Market Synopsis<\/p>\n
Cell Cryopreservation Market Size Was Valued at USD 10.23 Billion in 2023, and is Projected to Reach USD 62.71 Billion by 2032, Growing at a CAGR of 22% From 2024-2032.<\/p>\n
Sample cryopreservation means preserving the cell in the sub zero temperature below which the cells are frozen and stored in the liquid nitrogen for later use in gene mapping, medical treatments or in infertility treatments. There is tremendous programmable growth in the cell cryopreservation market across the world due to the usage in biological material storage, improved techniques in stem cell banking and redefined uses of cell-based techniques in research. It is applied in different fields such as stem cells, fertility treatment, cancer and drug development researches where it provides the capacity to maintain cells alive and active for long time without causing changes in their properties. In addition to this, the increase in demand of stem cells therapies and tissue engineering, surge in the applications of regenerative medicine along with a subsequent increasing requirement for cellular therapies and personalized drugs has boosted the growth of the market in the recent years.<\/p>\n
However, due to the life style transformation, chronic diseases like cancer and cardiovascular disorders are on the rise which in turn has fuelled the need for cryopreservation based biobanking solutions. It is more common today for biopharmaceutical companies, research facilities, and even hospitals to use cryopreservation for stem cells, immune cells, as well as many other bio related specimen. It is also advancing primarily due to growth in the frequency of clinical trials of cell and gene therapies, including cancer or genetic disorder treatments. Thus, the market of cell cryopreservation is projected to remain on its growth trajectory, with interest in efficient high-quality cryopreservation methods and solutions to improve cell vitality. However, it is worth pointing out that the academic collaboration with industry players to advance existing cryopreservation technologies is another primary driver of the market. This has resulted in development of such solutions as superior cryopreservation solutions, enhanced storage equipment that assists in enhancing the quality of cells preserved under freezing and thawing conditions. Rising knowledge about fertility preservation methods, particularly among patients with cancer, is another factor that is also driving the market because cryopreservation provides a solution to the preservation of oocytes, sperm, and embryos.<\/p>\n
Cell Cryopreservation Market Trend Analysis<\/p>\n
Advancements in Cryoprotective Agents<\/p>\n
The use of cryoprotective agents (CPAs) is considered one of the trends in the cell cryopreservation industry to capture the large market. CPAs are solutions employed to shield living cells from \u2026 detrimental effects caused by freezing. Optimizations the of CPAs have been a great step forward regarding the thawing and freezing processes and results relate in terms of cell viability. For example traditional solvents like Dimethyl sulfoxide (DMSO) have been known to be effective mostly but they are not environmentally friendly. However, new types of CPAs which have relatively low toxicity and enhanced compatibility with cells are being developed on the market to cope with the cellular damage related to cryopreservation.<\/p>\n
These enhancements are more helpful for difficult to isolate cells including stem cells and reproductive cells as are vital in clinical practice and discovery. The need for the development of CPAs that will guarantee better viability rates is nonetheless fundamental for the effectiveness of regenerative medicine and personalized therapies. Besides, continuous studies on the function of cryoprotective activity will help to develop low toxicity CPAs to achieve high effectiveness in cell cryopreservation and stimulate the market\u2019s growth.<\/p>\n
Expansion in Regenerative Medicine<\/p>\n
The growth of the two young industries presents a great opportunity for the advancement of the cell cryopreservation market. Stem cells are the most valuable element of regenerative medicine, and they are stored in a frozen state to be used again in the future. With stem cell based clinical trials continually on the rise and the call for stem cell based cures as treatment for diseases including neurodegenerative diseases, cardiovascular diseases and autoimmune diseases, efficient cryo-preservation techniques are gradually becoming essential.<\/p>\n
Furthermore, many stem cell therapies have gone commercial and the biobanks having stem cells as a therapeutic tool are other areas of high potential for companies in cryopreservation. Higher adoption of stem cell-based therapies in the field of healthcare and research institutions may also generate demand for better cryopreservation solutions to maintain cell structures and their functionality for periods such as years, making it a good growth prospect for its participants.<\/p>\n
Cell Cryopreservation Market Segment Analysis:<\/p>\n
Cell Cryopreservation Market Segmented based on Type, Application, and End User.<\/p>\n
By Type, Cell Freezing Media segment is expected to dominate the market during the forecast period<\/p>\n
Cell Freezing Media: Cell freezing media are highly essential in freezing process because they minimize damage to the cells. The media in the media contains cryoprotective agents which minimize the development of ice crystals that would have damaged the cells during thawing. The sub segment for other specialized media has been growing due to the continuously burgeoning requirement of specialized media for a plethora of sorts of cells containing stem cell, immune cell, as well as reproductive cell. In addition, there is also advancement in the types of media that are used to freeze cells, new serum-free and chemically defined formulations being examples of how the segment is growing.<\/p>\n
Equipment: Labeling and tracking systems, cryogenic storage, freezers and thawing machines are some of the important equipment required in storage. The need for better cryopreservation equipment for IVP, with different temperature regulating abilities and low cell mortality, is driving growth in this segment. Furthermore, automated storage systems\u2019 implementation is bound to improve biobanks\u2019 and research center\u2019s operation, thus strengthening the equipment segment.<\/p>\n
By Application , Stem Cells segment held the largest share in 2023<\/p>\n
Stem Cells: It is particularly the stem cells that play an important role in regenerative medicine, oncology, and tissue engineering which make an important application area for cryopreservation. Cryopreservation is a necessary method of storing stem cells for use later at longer periods, but still holding the cells in conditions that will allow them to be used in therapy. More clinical trials are being conducted with stem cells, and stem cell therapies are already being used in some sectors and, accordingly, the need for cryopreservation in this segment is increasing. Some of the other harbingers that are pushing growth of the market are biobanks that are maintaining stem cells for future uses in therapy.<\/p>\n
Sperm and Oocyte Cells: Sperm and oocytes freezing is critical in fertility management, especially for cancer clients who would soon undergo treatments that may harm their fertility. A growing number of people learning about options of preserving fertility on the one hand, along with rising interest in IVF procedures that require cryopreservation on the other hand, contribute to the growth of the segment. Furthermore, future growth is expected to be fuelled by continued innovation of cryopreservation procedures needed for enhancing viability of reproductive cells after thawing.<\/p>\n
Cell Cryopreservation Market Regional Insights: <\/p>\n
North America is Expected to Dominate the Market Over the Forecast period <\/p>\n
The growth in the number of facilities using cell cryopreservation and advanced health care infrastructure along with strong focus towards biotechnology and stem cell research has made North America the largest market in global cell cryopreservation. The dominant state in the market is the United States, where promising research activities are carried out in the field of stem cells, gene therapy and personalized medicine. Availability of expensive cryopreservation equipment and biobanking by the government has also ensured the continued growth of this market in the region.<\/p>\n
Moreover, the performing outcome of clinical trials and research activities, funding of biotechnological developments in the region also help it to dominate. Such factors as the increase in the number of chronic diseases as well as the increasing trend of using cells as therapeutic products in North America points to an increasing usage of cryopreservation services making it the single largest market for cell cryopreservation.<\/p>\n
Active Key Players in the Cell Cryopreservation Market<\/p>\n
Thermo Fisher Scientific (USA)<\/p>\n
Merck KGaA (Germany)<\/p>\n
Lonza Group (Switzerland)<\/p>\n
STEMCELL Technologies (Canada)<\/p>\n
Cytiva (USA)<\/p>\n
BioLife Solutions (USA)<\/p>\n
Cryoport, Inc. (USA)<\/p>\n
MilliporeSigma (Germany)<\/p>\n
Brooks Life Sciences (USA)<\/p>\n
VWR International (USA)<\/p>\n
Sartorius AG (Germany)<\/p>\n
Cryo Associates (USA)<\/p>\n
Princeton CryoTech (USA)<\/p>\n
Fujifilm Irvine Scientific (USA)<\/p>\n
Abcam (UK), Others Key Player.<\/p>\n
Key Industry Developments in the Cell Cryopreservation Market<\/p>\n
June 2023: The biopharma industry and BioLife Solutions, Inc. announced the launch of a new, large-capacity controlled-rate freezer (CRF) to expand their line of CRF products, which now come in three different shape factors. The IntelliRate i67C tabletop freezer fulfills a vital customer need for higher volume production of cell therapies.<\/p>\n
October 2022: The management teams of Pluristyx, panCELLa, and Implant Therapeutics are excited to announce their upcoming corporate merger, contingent upon shareholder approval. The combined business will integrate complementary portfolios to offer end-to-end customer support and enhance access to various induced pluripotent stem cell (iPSC)- related products and services. By combining the technological and service offerings, patients will receive ground-breaking cell therapies much faster.<\/p>\n","protected":false},"excerpt":{"rendered":"
Sample cryopreservation means preserving the cell in the sub zero temperature below which the cells are frozen and stored in the liquid nitrogen for later use in gene mapping, medical treatments or in infertility treatments.<\/p>\n","protected":false},"featured_media":21562,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-27174","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n